Eli Lilly’s Vaccine Acquisitions Signal a Strategy of Growth in New Areas
Many of Eli Lilly’s acquisitions this year double down in areas where the company is already a player, such as cancer and inflammatory disorders. Lilly is now broadening its scope to a new area, infectious disease, by buying three companies with vaccine programs for pathogens that currently have limited vaccination options, if any at all. […]
Eli Lilly’s Vaccine Acquisitions Signal a Strategy of Growth in New Areas Read More »
